Gilead Sciences, Inc. (GILD)
Last Price$82.810.5%
Market Cap$98.9bn
Financial ratios score
6/10
Revenue growth
(0.6%)
Industry median: 6.1%
Net income growth
23.4%
Industry median: (29.0%)
Free cash flow margin
27.4%
Industry median: (222.2%)
Net Debt / EBITDA
1.5x
Industry median: 1.0x
ROIC
16.3%
Industry median: (39.5%)
GILD Growth
Crunching data... Almost there!
GILD Profitability
Crunching data... Almost there!
GILD Bankruptcy probability
Crunching data... Almost there!
GILD Returns on capital
Crunching data... Almost there!
Discover more GILD fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
Is Gilead Sciences, Inc. (GILD) going bankrupt?
As of today, Gilead Sciences, Inc. has a low bankruptcy probability due to healthy solvency ratios.
What is Gilead Sciences, Inc. (GILD) ROIC?
As of today, Gilead Sciences, Inc. ROIC is 16.3%, based on the financial report for December 31, 2023 (Q4 2023).
Is Gilead Sciences, Inc. (GILD) ROIC good?
As of today, Gilead Sciences, Inc. ROIC is 16.3%, which is higher than 15%, that is considered a good ROIC ratio.